Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 1
1992 1
1993 4
1994 9
1995 10
1996 33
1997 28
1998 45
1999 52
2000 34
2001 36
2002 52
2003 45
2004 62
2005 77
2006 99
2007 98
2008 95
2009 107
2010 103
2011 127
2012 118
2013 132
2014 143
2015 127
2016 126
2017 107
2018 133
2019 113
2020 123
2021 120
2022 98
2023 101
2024 99
2025 133
2026 103

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,578 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean amsulosin[All Fields] (37 results)?
Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms.
Dunn CJ, Matheson A, Faulds DM. Dunn CJ, et al. Drugs Aging. 2002;19(2):135-61. doi: 10.2165/00002512-200219020-00004. Drugs Aging. 2002. PMID: 11950378 Review.
Pooled data based on patients receiving tamsulosin 0.4 or 0. 8mg once daily indicate maintenance of efficacy for up to 6 years. Tamsulosin 0.4 mg once daily was of similar efficacy to alfuzosin 2.5 mg three times daily, with less tendency to cause hypotensive effect …
Pooled data based on patients receiving tamsulosin 0.4 or 0. 8mg once daily indicate maintenance of efficacy for up to 6 years. Ta …
Safety and Feasibility of Opening Tamsulosin Capsules for Enteral Feeding Tube Administration.
Fazio V, Altshuler J, Song YB. Fazio V, et al. J Pharm Pract. 2024 Oct;37(5):1164-1169. doi: 10.1177/08971900241233615. Epub 2024 Feb 20. J Pharm Pract. 2024. PMID: 38379309
Purpose: Tamsulosin is formulated as sustained release beads within a capsule to prevent rapid absorption and associated hypotension. ...Tamsulosin capsules may be opened and administered via enteral feeding tubes if administered with content integrity intact....
Purpose: Tamsulosin is formulated as sustained release beads within a capsule to prevent rapid absorption and associated hypotension. …
Real-world safety assessment of tamsulosin based on adverse event analysis from the FAERS database.
Zhang Z, Lv L, Jiang F, Guan S, He D, Song H, Sun W, Tian F, Jiang S. Zhang Z, et al. Sci Rep. 2025 Oct 21;15(1):36726. doi: 10.1038/s41598-025-20739-7. Sci Rep. 2025. PMID: 41120617 Free PMC article.
Tamsulosin, an alpha-1-adrenergic receptor antagonist, is a commonly used drug in urology. The purpose of this study was to evaluate the safety of tamsulosin during its use by examining the FDA Adverse Event Reporting System (FAERS) database. ...
Tamsulosin, an alpha-1-adrenergic receptor antagonist, is a commonly used drug in urology. The purpose of this study was to evaluate …
Dutasteride/tamsulosin: in benign prostatic hyperplasia.
Keating GM. Keating GM. Drugs Aging. 2012 May 1;29(5):405-19. doi: 10.2165/11208920-000000000-00000. Drugs Aging. 2012. PMID: 22550968 Review.
The mean change from baseline in the total International Prostate Symptom Score was significantly greater with dutasteride plus tamsulosin than with dutasteride or tamsulosin alone after 2 years (primary endpoint) and 4 years of therapy. ...In the CombAT trial, heal …
The mean change from baseline in the total International Prostate Symptom Score was significantly greater with dutasteride plus tamsulosi …
Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men: A Randomized Clinical Trial.
Bauer SR, Kenfield SA, Oni-Orisan A, Shlipak MG, Lu K, Rios N, Pearce R, Harmon J, McCulloch CE, Huang L, Steinman MA, Breyer BN. Bauer SR, et al. JAMA Netw Open. 2026 Jul 1;9(7):e2621639. doi: 10.1001/jamanetworkopen.2026.21639. JAMA Netw Open. 2026. PMID: 42406401 Free PMC article. Clinical Trial.
The ability of N-of-1 deprescribing trials to identify who may benefit from discontinuing chronic tamsulosin therapy is unknown. OBJECTIVE: To determine if N-of-1 deprescribing trials can identify older men who are receiving minimal benefit from tamsulosin therapy f …
The ability of N-of-1 deprescribing trials to identify who may benefit from discontinuing chronic tamsulosin therapy is unknown. OBJE …
Pumpkin seed oil (Cucurbita pepo) versus tamsulosin for benign prostatic hyperplasia symptom relief: a single-blind randomized clinical trial.
Zerafatjou N, Amirzargar M, Biglarkhani M, Shobeirian F, Zoghi G. Zerafatjou N, et al. BMC Urol. 2021 Oct 19;21(1):147. doi: 10.1186/s12894-021-00910-8. BMC Urol. 2021. PMID: 34666728 Free PMC article. Clinical Trial.
Patients were randomized into two groups. One group received 0.4 mg tamsulosin every night at bedtime and the other received 360 mg pumpkin seed oil twice a day. ...None of the patients in the pumpkin group experienced drug side effects, while dizziness (5.9%), headache (2 …
Patients were randomized into two groups. One group received 0.4 mg tamsulosin every night at bedtime and the other received 360 mg p …
The effect of tamsulosin in postoperative urinary retention: a meta-analysis of randomized controlled trials.
Gao B, Zhang D, Wang Y, Wang Z, Wang Z. Gao B, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Mar;396(3):441-451. doi: 10.1007/s00210-022-02343-y. Epub 2022 Nov 29. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36445384 Review.
Tamsulosin is a therapeutic drug of alpha-adrenergic antagonists. Previous randomized controlled trials and retrospective analyses have proved the efficacy of tamsulosin on many urinary system diseases. ...Tamsulosin could significantly reduce the risk of POU …
Tamsulosin is a therapeutic drug of alpha-adrenergic antagonists. Previous randomized controlled trials and retrospective analyses ha …
Tamsulosin for benign prostatic hyperplasia.
Wilt TJ, Mac Donald R, Rutks I. Wilt TJ, et al. Cochrane Database Syst Rev. 2003;(1):CD002081. doi: 10.1002/14651858.CD002081. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2011 Sep 07;(9):CD002081. doi: 10.1002/14651858.CD002081.pub2. PMID: 12535426 Updated.
Discontinuations from treatment for any reason and discontinuations "due to adverse events" were similar in the low dose tamsulosin (0.2 mg) and placebo groups but increased to 16% in trials utilizing a 0.8 mg dose of tamsulosin. ...Adverse effects increased markedl …
Discontinuations from treatment for any reason and discontinuations "due to adverse events" were similar in the low dose tamsulosin ( …
2,578 results